Ferring Pharmaceuticals (Asia) Co. Ltd.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$16,564
Doctors Paid
4
Transactions
4
2023 Total
$5,600
Payment Breakdown by Category
Consulting$16,564 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,564 | 4 | 100.0% |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Reproductive Endocrinology | $13,064 | 2 | $6,532 |
| Urology | $3,500 | 2 | $1,750 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Kevin Doody, Md, MD | Reproductive Endocrinology | Bedford, TX | $7,464 | $0 |
| Craig Witz, M.d, M.D | Reproductive Endocrinology | Houston, TX | $5,600 | $0 |
| Dr. Neal Shore, Dr, DR | Urology | Myrtle Beach, SC | $1,750 | $0 |
| Elward Crawford, Md, MD | Urology | San Diego, CA | $1,750 | $0 |
About Ferring Pharmaceuticals (Asia) Co. Ltd.
Ferring Pharmaceuticals (Asia) Co. Ltd. has made $16,564 in payments to 4 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. In 2023, the company paid $5,600. The top product by payment volume is FIRMAGON ($3,500).
Payments were distributed across 2 medical specialties. The top specialty by payment amount is Reproductive Endocrinology ($13,064 to 2 doctors).
Payment categories include: Consulting ($16,564).